Indication
Yellow fever
11 clinical trials
11 products
1 drug
Clinical trial
Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril in AdultsStatus: Active (not recruiting), Estimated PCD: 2022-05-23
Product
Yellow fever vaccineProduct
HydroVax-002Clinical trial
A Double Blind, Randomized, Placebo-Controlled, Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated Yellow Fever Virus Vaccine, HydroVax-002 YFV, in Healthy AdultsStatus: Completed, Estimated PCD: 2022-10-19
Clinical trial
The Yellow Fever Vaccine Immunity in HIV Infected Patients: Studies of Immunological Responses at 10 Years (ANRS 0146s NovaaTen)Status: Not yet recruiting, Estimated PCD: 2024-11-01
Product
Yellow fever vaccinationClinical trial
Human Immune Responses to Yellow Fever VaccinationStatus: Recruiting, Estimated PCD: 2025-12-31
Product
Yellow Fever VaccineClinical trial
A Phase I, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA 720 Adjuvant in 18-45 Year Old Healthy AdultsStatus: Completed, Estimated PCD: 2018-03-22
Product
ISA-720Clinical trial
A Phase I/II Study Of The Immunogenicity Of The Yellow Fever Vaccine 17D (YFVax®) In Adults With Prior 17D VaccinationStatus: Recruiting, Estimated PCD: 2024-11-01
Product
17DProduct
MVA Smallpox VaccineProduct
MVA-BN Yellow Fever VaccineProduct
YF Vax 17D StrainClinical trial
Non- Inferiority Fractional-doses Trial for Yellow Fever VaccineStatus: Completed, Estimated PCD: 2020-03-30
Clinical trial
The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationStatus: Active (not recruiting), Estimated PCD: 2025-06-30
Clinical trial
Modulating Endoplasmic Reticulum Stress as a Prophylactic Approach Against Symptomatic Viral InfectionStatus: Completed, Estimated PCD: 2023-07-31
Drug
MetforminProduct
Calcium and Vitamin DClinical trial
Estudio Sobre Respuesta de Anticuerpos Neutralizantes Contra la Fiebre Amarilla Cuatro a Siete años después de Vacunar Una población pediátrica Entre Los 12 y 23 Meses de Edad en ArgentinaStatus: , Estimated PCD: 2023-05-31
Clinical trial
Yellow Fever Human Infection Model With YF-17DStatus: Recruiting, Estimated PCD: 2023-07-01